<code id='B6DF1DC1C1'></code><style id='B6DF1DC1C1'></style>
    • <acronym id='B6DF1DC1C1'></acronym>
      <center id='B6DF1DC1C1'><center id='B6DF1DC1C1'><tfoot id='B6DF1DC1C1'></tfoot></center><abbr id='B6DF1DC1C1'><dir id='B6DF1DC1C1'><tfoot id='B6DF1DC1C1'></tfoot><noframes id='B6DF1DC1C1'>

    • <optgroup id='B6DF1DC1C1'><strike id='B6DF1DC1C1'><sup id='B6DF1DC1C1'></sup></strike><code id='B6DF1DC1C1'></code></optgroup>
        1. <b id='B6DF1DC1C1'><label id='B6DF1DC1C1'><select id='B6DF1DC1C1'><dt id='B6DF1DC1C1'><span id='B6DF1DC1C1'></span></dt></select></label></b><u id='B6DF1DC1C1'></u>
          <i id='B6DF1DC1C1'><strike id='B6DF1DC1C1'><tt id='B6DF1DC1C1'><pre id='B6DF1DC1C1'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:leisure time    Page View:9556
          Darron Cummings/AP

          Eli Lilly said Friday that it will acquire Dermira, a small biotech developing drugs for chronic skin conditions, for $1.1 billion.

          The centerpiece of the deal is the Dermira drug called lebrikizumab that aims to treat people suffering from moderate-to-severe atopic dermatitis, the most common form of eczema, a disease characterized by inflamed, itchy, and scaly skin.

          advertisement

          Phase 3 clinical trials of lebrikizumab in atopic dermatitis are underway. If successful, the drug could compete against Dupixent, which has grown into a commercial blockbuster for Regeneron Pharmaceuticals and Sanofi.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more
          Roche to buy Carmot Therapeutics, developer of obesity drugs
          Roche to buy Carmot Therapeutics, developer of obesity drugs

          SebastienBozon/AFPviaGettyImagesLONDON—Theboomingobesitymarketisattractinganotherplayer,aspharmagian

          read more
          In Memoriam: Notable people who died in 2023
          In Memoriam: Notable people who died in 2023

          1:29AlanArkinattendsthe26thAnnualScreenActorsGuildAwardsatTheShrineAuditoriumonJan.19,2020inLosAngel

          read more

          Study gives hint on South Asians’ higher risk of cardiovascular disease

          AdobeAgrowingbodyofdatashowthatSouthAsiansareatgreaterriskofdevelopingheartdiseasethanwhitepeople,an